Vaxinia: an experimental cancer-killing virus

post-image

An experimental cancer-killing virus (Vaxinia) has been administered to a human patient for the first time, with hopes the testing will ultimately reveal evidence of a new means of successfully fighting cancer tumors in humans.  

Co-developers of the oncolytic virus drug are the City of Hope cancer care and research center in Los Angeles and Australia-based biotech company Imugene.  The trial is for two years.

Previous research has shown the drug can harness an animal immune system to hunt and destroy cancer cells.  Another monocolytic virus drug T-VEC (Talimogene laherparepvec) is used to treat melanoma in humans.

Article:  https://www.sciencealert.com/first-patient-injected-with-experimental-cancer-killing-virus-in-new-clinical-trial




What do you think?


You must be logged in to post a comment.
Comments

Related Posts

Healthcare

post-image

New pain relief though nerve cooling implant
26 July 2022 by Trevor Rowe 0 Comments

Healthcare

post-image

A defibrillator near every home
23 July 2022 by Lynn Wood 0 Comments

Healthcare

post-image

Phage therapy .. a new frontier in healthcare
26 June 2022 by Trevor Rowe 0 Comments